Objective: Restless legs syndrome (RLS) is a common sleep disorder. In addition to disturbing sleep, however, RLS also affects quality of life and may lead to significant fatigue or psychiatric symptoms. This study was an examination of the effects of RLS on quality of life and symptoms of anxiety and depression.
INTRODUCTION
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by 5 key criteria determined by the International Restless Legs Syndrome Study Group (IRLSSG).
Patients feel uneasy, uncomfortable, and have difficulty falling asleep due to an urge to move the extremities, most often the legs, which typically starts in the evening or while at rest, and is characterized by unexplained, painful sensorimotor symptoms, such as sensations of burning, ache, tingling, chills, and freezing. [1] [2] [3] The prevalence of RLS observed in the Turkish population has been reported to be between 3.19% and 22.2%. It is seen twice as frequently in the female gender and the incidence increases with age. [4] [5] [6] Chronic sleep deprivation is particularly prominent in RLS patients with daytime symptoms. [7] Psychiatric symptoms that affect the quality of life, such as fatigue, depression, and anxiety, have been observed more frequently in RLS patients compared with healthy individuals. [8] [9] [10] The Short Form Health Survey (SF-36), which evaluates quality of life, and the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory (BDI), employed in the diagnosis of anxiety and depression symptoms, are widely used to evaluate the mental and physical health status of patients. There are currently few studies of the impact of RLS on quality of life in the Turkish population.
The aim of this study was to investigate the effects of RLS on the quality of life of patients and the psychiatric variables of anxiety and depression.
MATERIALS AND METHODS
This study included 55 patients (Group I) who presented at a neurology outpatient clinic. These patients met the diagnostic criteria for idiopathic RLS and had no secondary causes, including RDS, other sleep disorders, iron-deficiency anemia, endocrine diseases, renal failure, pregnancy, or breastfeeding. The control group (Group II) consisted of 35 healthy volunteers without any diagnosed psychiatric, chronic, or systemic disease or sleep disorder. [1] Patients who had symptoms of insomnia but who did not meet the RLS diagnostic criteria, those who had been diagnosed with RLS previously and received regular treatment, and individuals who described snoring or reported witnessed apnea due to possible sleep apnea syndrome were excluded from the study. Individuals who had not completed at least 5 years of formal basic education and those who had past or present history of smoking or alcohol use were also excluded. Written, informed consent was obtained from the patients enrolled in the study. Local ethics committee approval (2015/8) was obtained.
The length of formal education, and the anthropometric measurements of body mass index (BMI) and waistto-hip ratio of all of the participants were documented. Laboratory data related to fasting blood glucose, urea, creatinine, uric acid, total cholesterol, triglyceride, highdensity lipoprotein cholesterol, low-density lipoprotein cholesterol, iron, ferritin, triiodothyronine, thyroxine, thyroid-stimulating hormone, vitamin B12, folate, C-reactive protein, sedimentation rate, and hemogram values were recorded.
A neurological examination was performed and sleep disorders were evaluated by a neurologist during face-to-face interviews. Validated Turkish versions of the following scales were used to assess the participants.
The Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and the Insomnia Severity Index (ISI) were used to evaluate sleep status; the presence and severity of RLS were determined using the IRLSSG rating scale; the level of existing depression and anxiety was measured with the BDI and the BAI; and the Fatigue Severity Scale (FSS) and the SF-36 were used to assess fatigue and quality of life.
The IRLSSG scale is composed of 10 questions, each of which is graded between 0 and 4 points. Based on the total score, the severity of RLS is considered mild (0-10), moderate (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , severe (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , or very severe (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) . [11] The PSQI is a 19-item self-report scale that assesses sleep quality and indicates the presence of sleep disorders. A PSQI total score greater than 5 indicates poor sleep. [12] The ESS was developed by Johns et al. to qualitatively and quantitatively measure sleep status and to assess daytime sleepiness. The total score can range from 0 to 24 points, and a score greater than 10 generally indicates excessive daytime sleepiness. [13, 14] The ISI is used for the clinical evaluation of insomnia. This Likert-type scale consists of 7 questions with a maximum possible score of 28 points. [15, 16] The BAI and BDI are both 21-item Likert-type, self--report evaluations. Items are rated between 0 and 3 points, with a total score that ranges between 0 and 63 points. The score is proportional to the severity of anxiety or depression. [16, 17] The FSS is a self-report scale consisting of 9 items, each rated between 1 and 7 points. The final score (total points/ 9) is directly proportional to the severity of fatigue. [18] The SF-36 questionnaire consists of components measuring physical functioning (PF), social functioning (SF), role limitation due to physical problems (RP), role limitation due to emotional difficulties (RE), mental health (MH), energy and vitality (VT), bodily pain (BP), and general health perception (GH). Quality of life is measured using scoring algorithms that convert each component into a scale 0 to 100. A lower result indicates greater disability and less quality of life. Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were also calculated using a standard algorithm. [19] The laboratory results and questionnaire data of all of the individuals in Groups I and II were compared and the statistical significance was analyzed.
Statistical analysis
IBM SPSS Statistics for Windows, Version 22.0 software (IBM Corp., Armonk, NY, USA) was used to perform the statistical analysis. Mean, SD, median, minimum, maximum, frequency, and percentage values were used as descriptive statistics. The distribution of the variables was evaluated using the Kolmogorov-Smirnov test. Student's t-test was used for continuous variables and a chi-square test for categorical variables. Pearson correlation analysis was applied to examine relationships between variables. Multivariate linear regression analysis was employed to determine dependent variables that might affect the SF-36 score in patients with RLS. The results were evaluated with a confidence interval of 95% and a significance level of p<0.05.
RESULTS
A total of 90 participants who met the inclusion criteria were enrolled in the study. The mean age of the 55 patients in Group I (7 male, 48 female) was 40.05±10.2 years, and it was 35.89±9.4 years for the 35 healthy individuals in Group II (8 male, 27 female) ( Table 1) . In Group I, the mean age of onset of RLS was 32.18±8.46 years with a mean duration of RLS of 7.18±7.36 years. The most common symptom was sensory complaints (n=50, 90.9%) and 30 (54.5%) patients had daytime symptoms. According to the IRLSSG rating scale, the RLS symptoms were mild in 1.8% of the participants, moderate in 29.1%, severe in 43.6%, and very severe in 25.4%. (Table 2) .
No statistically significant difference was found in terms of age, gender, length of education, height, weight, waist circumference, hip circumference, or waist-to-hip ratio measurements compared with the control group. However, the mean BMI was significantly greater in patients with RLS (p=0.005) ( Table 1) . No statistically significant difference was detected between the groups in the laboratory data. There was a positive correlation between the BMI and the PSQI (r=0.340; p=0.001) and BAI (r=0.248; p=0.018).
The PSQI, EPS, SCS, ISI, BDI, BAI and FSS results were significantly higher in cases with RLS relative to the control group (p=0.001, p=0.001, p=0.001, p=0.001, p=0.001, and p=0.001, respectively) ( Table 3 ). In addition, the SF-36 scale scores were significantly lower in the PF, RP, VT, SF, and MH components, as well as the PCS, in the RLS group compared with the control group (p=0.044, p=0.008, p=0.016, p=0.007, p=0.017, and p=0.001, respectively) ( Table 3) .
The relationship between possible factors that may affect the PCS was investigated using Pearson correlation analysis. There was a negative correlation between the PCS and the IRLSSG scale, FSS, ESS, PSQI, BDI, and BAI 
DISCUSSION
In this study, we found a decrease in the quality of life determined by the SF-36, and the BDI and BAI revealed an increased frequency of the psychiatric symptoms of anxiety and depression. In addition, significantly higher levels of fatigue and depressive symptoms were found to be the most important determinants of poorer PCS scores in RLS patients.
Examinations of the relationship between RLS and SF-36 results in different societies have revealed differences. In their study of 985 members of the Japanese population, Kubo et al. [20] found significant decreases in all physical components as well as those related to vitality, social functioning, and emotional functioning in RLS patients. In a study of 3433 patients in the US, lower scores in all areas of the SF-36 were detected in individuals with RLS, but the decline in physical domains was particularly emphasized. [21] Kushida et al. [22] suggested that RLS had a greater effect on the physical components of the SF-36 than its mental components. In this study, the PF, RP, VT, SF, and MH subcomponents of the SF-36 and the PCS score were significantly lower in idiopathic RLS patients when compared with healthy individuals.
It has been established that general and abdominal adiposity is typically greater in individuals with RLS, and that this relationship is meaningful, particularly among female patients. [23, 24] Patients with RLS generally have a higher BMI than those who do not. It has been reported that BMI may be a risk factor for nocturnal eating behavior, which is a specific component of clinical spectrum of RLS. [25] The prevalence of psychiatric conditions such as depression, anxiety, and eating disorders is higher in obese patients compared with the general population. [26, 27] In an evaluation of sleep disorders in individuals with obesity, the PSQI, ISI, and ESS scores were statistically significantly higher. [28] A cohort study involving 983 adults revealed that sleep duration of fewer than 5 hours was associated with a 2.8-times greater likelihood of obesity and increased with each 1.6 kg/m 2 in BMI. [29] Abnormalities in the hypothalamic-pituitary-adrenal axis and cortisol levels have been associated with the development of emotional disorders, obesity, and metabolic syndrome in patients with RLS. [30, 31] In this study, the BMI was significantly higher in idiopathic RLS patients, consistent with the association described in the literature. In addition, there was a positive relationship between BMI and the sleep quality and anxiety scores.
In a study of 85 RLS patients performed in the UK using the SF-36, Abetz et al. [32] reported that RLS appeared to have a significant effect on quality of life. In another study, there was a significant correlation between the severity of RLS and all physical and mental health scale scores. [33] In this study, as in much of the literature, there was a negative correlation between PCS scores and RLS severity, but there was no correlation between RLS onset and Several factors that could have an impact on the quality of life of RLS patients have been investigated. Among those with RLS, depression and anxiety have been reported to be more common than in healthy individuals. [9, 10] Depression has been observed 2 to 4 times more frequently in RLS. [34] [35] [36] Dopaminergic dysfunction may be the most important factor affecting the pathophysiology of both depression and RLS. [37, 38] A significant reduction in D2 receptors in putamen nuclei in patients with RLS has been shown to be associated with symptom severity. [39] The contribution of chronic sleep deprivation contributes to depression, especially in patients with severe RLS with daytime symptoms. [40, 41] Svetel et al. [42] indicated that symptoms of depression and anxiety were among the greatest potential determinative factors for deterioration in all of the SF-36 components. In our study, anxiety and depression symptoms were significantly higher in RLS patients with daytime sleepiness, and depression symptoms were among the influential variables for the PCS score.
More than half of patients with chronic fatigue have a diagnosis of a sleep disorder, such as RLS, obstructive sleep apnea, or periodic limb movement disorder. [43] Fatigue and daytime sleepiness have been analyzed in RLS patients and were determined to have an effect on the quality of life. [8] Our research also found that fatigue was among the factors that may contribute to a worse PCS score.
The most important limitation of this study is that additional assessment tools beyond the PSQI, such as polysomnography, could not be applied. A careful evaluation was used to try to eliminate other possible sleep disorders. Furthermore, the study did not examine the effect of treatment on quality of life or depression and anxiety in RLS patients.
CONCLUSION
The results of this study indicated that idiopathic RLS was associated with a poorer quality of life and with the presence of the psychiatric symptoms of anxiety and depression. Further studies are needed to determine possible neurophysiological mechanisms and to evaluate the effects of treatment.
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